Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Contraception |
Condom; Condoms |
Clinical Trial: Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
This study is not yet open for patient recruitment.
Verified by Schering AG, Germany December 2005
|
Purpose
The purpose of the study is to determine safety and efficacy of long-cycle regimens of an oral contraceptive.
| Condition | Intervention | Phase |
|---|---|---|
| Contraception | Drug: SH T 00186 D | Phase III |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Multicenter, Open, Randomized, Parallel-Group Comparison to Assess the Safety and Efficacy of the Oral Contraceptive SH T 00186 D in Extended Cycles Vs. a Standard Regimen in Healthy Female Volunteers for Up to Two Years
Further study details as provided by Schering AG, Germany:
Primary Outcomes: Number of days with bleeding/spotting
Secondary Outcomes: Parameters of safety and tolerability; Number of unintended pregnancies
Secondary Outcomes: Parameters of safety and tolerability; Number of unintended pregnancies
Study start: December 2005
Eligibility
Ages Eligible for Study: 18 Years - 35 Years, Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Healthy women who desire contraception
Exclusion Criteria:
- Contraindication against use of hormonal contraceptives
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00266032
Schering AG, Germany, Medical affairs Europe: +49 30 46811800
Schering AG Germany, Medical affairs Canada: +1 8665969652
Schering AG Germany, Medical affairs Canada: +1 8665969652
Canada, Quebec
Ste Foy, Quebec, G1V 4P9, Canada
Shawinigan, Quebec, G9N 2H6, Canada
Québec, Quebec, G1S 2L6, Canada
Montreal, Quebec, H1T 1P6, Canada
Drummondville, Quebec, J2B 1H8, Canada
Pointe-Claire, Quebec, H9R 4S3, Canada
Germany
Berlin, 13187, Germany
Berlin, 10115, Germany
Berlin, 10247, Germany
Berlin, 12435, Germany
Hamburg, Pract: 21073 / Mail: 21149, Germany
Germany, Baden-Württemberg
Karlsruhe, Baden-Württemberg, 76199, Germany
Ettlingen, Baden-Württemberg, 76275, Germany
Germany, Bayern
Nürnberg, Bayern, 90461, Germany
Krumbach, Bayern, 86381, Germany
Ansbach, Bayern, 91522, Germany
Germany, Hessen
Dietzenbach, Hessen, 63128, Germany
Frankfurt/Main, Hessen, 65929, Germany
Frankfurt/Main, Hessen, 60439, Germany
Frankfurt/Main, Hessen, 60322, Germany
Frankfurt/Main, Hessen, 65936, Germany
Mühlheim, Hessen, 63165, Germany
Germany, Niedersachsen
Osnabrück, Niedersachsen, 49074, Germany
Hannover, Niedersachsen, 30459, Germany
Bovenden, Niedersachsen, 37120, Germany
Germany, Saarland
HOMBURG / SAAR, Saarland, 66421, Germany
Germany, Sachsen
Wurzen, Sachsen, 04808, Germany
Germany, Sachsen-Anhalt
Magdeburg, Sachsen-Anhalt, 39112, Germany
Magdeburg, Sachsen-Anhalt, 39104, Germany
Bernburg, Sachsen-Anhalt, 06406, Germany
Jessen, Sachsen-Anhalt, 06917, Germany
Magdeburg, Sachsen-Anhalt, 39130, Germany
Germany, Thüringen
Gera, Thüringen, 07545, Germany
Jena, Thüringen, 07747, Germany
Kahla, Thüringen, 07768, Germany
Gera, Thüringen, 07545, Germany
Netherlands
Groningen, 9713 GZ, Netherlands
Study chairs or principal investigators
Schering AG, Germany Medical Affairs, Study Director, Phone Europe: +49 30 46811800, Phone Canada: +1 8665969652
More Information
Study ID Numbers: 308683
Last Updated: December 14, 2005
Record first received: December 14, 2005
ClinicalTrials.gov Identifier: NCT00266032
Health Authority: Canada: Health Canada; Germany: Federal Institute for Drugs and Medicinal Devices; Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
ClinicalTrials.gov processed this record on 2006-01-10
Last Updated: December 14, 2005
Record first received: December 14, 2005
ClinicalTrials.gov Identifier: NCT00266032
Health Authority: Canada: Health Canada; Germany: Federal Institute for Drugs and Medicinal Devices; Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
ClinicalTrials.gov processed this record on 2006-01-10
Resources
- All About Tubal Sterilization (Planned Parenthood Federation of America)
- Anticonceptivos Orales Combinados FAQ (Family Health International)
email this page
print this page
bookmark this page
feedback on this page
